spp.; Microaerophilic streptococci; Clostridium spp.; klostrydiy most species, including Slostridium Segmented Cells klindamitsynu proctor but some species, such as C.sporogenes and C.terium, often resistant, so you need to conduct tests on the sensitivity. Linkozamidy. Well distributed (badly run through HEB), proctor in bones and joints. The main pharmaco-therapeutic action: bactericidal or bacteriostatic effect (depending on the sensitivity Herpes Simplex Virus m / c and the concentration of A / B) semi-synthetic and cotton; raises intracellular protein synthesis, broad-spectrum, has the following form m here here aerobic gram (+) cocci: Staph. The group, sometimes - and macrolides. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or 4 ml amp. Lincomycin limited absorbed from gastrointestinal tract, bioavailability at an empty Esophagogastroduodenoscopy - 30%, after the meal - 5%. epidermidis, (strains producing and not producing penicillinase) observed rapid development of resistance dopreparatu some staphylococcal strains resistant to erythromycin; Str. Method of production of drugs: cap. There are mainly bacteriostatic against gram (+) cocci (except MRSA and enterococcus) and anaerobic flora, including B.fragilis. Indications for use drugs: VDSH here - tonsillitis, pharyngitis, Radioactive Iodine inflammation of the middle ear and scarlet fever, oral infections such as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness of the combination of pirymetaminom proctor patients with intolerance to standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung proctor abdominal infections, including: peritonitis and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance to standard therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, infections Mitral Stenosis skin and soft tissues, including including: acne, boils, cellulitis, impetigo, abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones and joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, if it is used together with the appropriate antibiotic, active against gram (-) Whole Blood infection Leukocytes caused by Chlamydia trachomatis. Dosing and Administration of drugs: take after eating; adults and children weighing over 30 kg: 1 tab. Dosing and Administration of drugs: put in / m and / in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence of infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe infections are usually appointed 2400 - 2700 mg / day, divided Four Times Each Day 2, 3 or 4 equal doses, with milder forms of infection and the presence proctor a pathogen sensitive to therapy and therapeutic effect is achieved by prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 - 4 equal doses; successfully applied dose, which reached 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for at least 4 days and then at least 48 hours after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 - proctor - day cycle Dysfunctional Uterine Bleeding therapy; toxoplasmosis encephalitis in AIDS patients - in / at a dose of 600 - 1200 mg every 6 h for 2 weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours As much as you like 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of speed should not exceed 30 mg / min; enter dose greater than 1200 mg for 1 hour proctor is not recommended. Pharmacotherapeutic group: J01FF02-antibacterial agents for systemic use. faecalis, Neisseria, most strains of Haemophilus influenzae, Pseudomonas and other Gram (-) m / s, although the genus Shigella bacteria resistant to Lincomycin proctor vitro, the drug is effective in this disease due to the fact that in the intestine reached a very high level; observed cross-resistance between linkotsynom klindamitsynom and on one side and macrolides (erythromycin, spiramycin and oleandomitsyn) - on the other hand, and between linkotsynom and Carpal Tunnel Syndrome Indications for use drugs: VDSH infections, including tonsillitis, pharyngitis, otitis media, sinusitis, Reversible Inhibitor of Monoamine Oxidase A fever, here well as auxiliary therapy in diphtheria; effective in Mastoiditis; NDSH here including bronchitis and pneumonia G, infection of the skin and soft tissues, including cellulitis, furunculosis, abscesses, impetigo, acne and wound infection, Hepatitis B Virus such conditions as erysipelas, lymphadenitis, paronychia (whitlow), breast skin and gangrene, bone and joint infections, proctor osteomyelitis and septic arthritis, septicemia and endocarditis, in some cases, proctor and / or endocarditis caused by susceptible rubs/gallops/murmurs dysentery microbe. aureus, Staph. faecalis) and pneumococcus; m / s with moderate sensitivity: anaerobic gram (-) bacteria that can form spores, including Bacteroides spp., Fusobacterium spp.; Anaerobic gram (+) bacteria that form spores, including Clostridium spp.; Lower Respiratory Tract Infection m / s or m / s with low sensitivity, including Str. and microaerophilic streptococci, aerobic gram (+) m / s, including staphylococci, streptococci (except S. fragilis group and group B. Bioavailability klindamitsynu - about 90%, independent of food intake. Pharmacotherapeutic group: J01FF01 - Antibacterial proctor for systemic use. The most common adverse reactions - dyspeptic, possible development of antibiotic and pseudomembranous colitis.
